pancreatic cancer
Conditions
Interventions
Perform percutaneous ascites injection and perform transanal EUS-FNA to collect ascites.
Sponsors
Aichi Cancer Center Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Cases who the age at the time of obtaining consent is 20 years or older. 2) Cases who written consent has been obtained from the patient themselves. 3) Cases who a diagnosis of pancreatic cancer can be made through various imaging diagnostics. 3) Cases who it is believed that EUS-FNA can be safely performed.
Exclusion criteria
Exclusion criteria: Cases with concomitant cancers in other organs that are under treatment. Cases with ascites or disseminated nodules on imaging. Cases with a known allergy to lidocaine. Cases that the attending physician deems unsuitable for inclusion in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety | — |
Secondary
| Measure | Time frame |
|---|---|
| Success Rate of the Technique Positive Rate of Cytological Examination of Lavage Peritoneal Fluid using EUS-FNA Volume of Peritoneal Fluid Collected by EUS-FNA Biochemical Analysis of Peritoneal Fluid Tumor Markers in Peritoneal Fluid | — |
Countries
Japan
Contacts
Public ContactNozomi Okuno
Aichi Cancer Center Hospital Department of Gastroenterology
Outcome results
None listed